​

Madrigal Pharmaceuticals Ownership | Who Owns Madrigal Pharmaceuticals?

OverviewForecastRevenueFinancialsChartTranscripts

Madrigal Pharmaceuticals Ownership Summary

Madrigal Pharmaceuticals is owned by 81.81% institutional investors, 5.87% insiders, and 12.31% retail investors. Janus henderson group is the largest institutional shareholder, holding 9.00% of MDGL shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.62% of its assets in Madrigal Pharmaceuticals shares.

MDGL Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockMadrigal Pharmaceuticals81.81%5.87%12.31%
SectorHealthcare Stocks 50.50%12.33%37.17%
IndustryBiotech Stocks 49.09%12.06%38.85%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Janus henderson group2.02M9.00%$1.05B
Vanguard group1.81M8.05%$1.05B
Baker bros. advisors lp2.14M7.38%$1.15B
Blackrock1.43M7.14%$399.86M
Rtw investments, lp1.99M6.87%$1.07B
Avoro capital advisors1.83M6.31%$984.41M
Paulson1.34M4.62%$719.52M
Blackrock funding, inc. /de1.20M4.14%$644.75M
Vanguard capital management835.67K2.88%$448.71M
Wellington management group llp825.71K2.84%$443.37M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Paulson1.34M27.94%$719.52M
Rtw investments, lp1.99M9.14%$1.07B
Ally bridge group (ny)32.66K9.12%$14.98M
Avoro capital advisors1.83M8.84%$984.41M
Baker bros. advisors lp2.14M5.77%$1.15B
Rock springs capital management lp175.00K4.59%$93.97M
Tri locum partners lp68.27K4.51%$36.66M
Iron triangle partners lp58.38K3.81%$26.78M
Nan fung group5.67K2.32%$3.05M
Cannon global investment management1.50K2.28%$805.42K

Top Buyers

HolderShares% AssetsChange
Janus henderson group2.02M0.52%433.80K
Ubs group401.71K0.03%283.93K
Blackrock1.43M0.01%216.86K
Norges bank213.89K0.01%213.89K
Sixth street partners management company184.32K0.01%184.32K

Top Sellers

HolderShares% AssetsChange
Blackrock funding, inc. /de1.20M0.01%-359.19K
Ra capital management---204.50K
Bain capital life sciences investors---197.00K
Adage capital partners gp---185.33K
Fmr356.20K0.01%-155.53K

New Positions

HolderShares% AssetsChangeValue
Norges bank213.89K0.01%213.89K$114.85M
Sixth street partners management company184.32K0.01%184.32K$98.97M
Holocene advisors, lp152.92K0.18%152.92K$82.11M
Balyasny asset management79.01K0.05%79.01K$42.42M
Iron triangle partners lp58.38K3.81%58.38K$26.78M

Sold Out

HolderChange
Marquette asset management-1.00
Atlas capital advisors-1.00
Sjs investment consulting-1.00
True wealth design-1.00
Td capital management-1.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20264346.90%23,752,677-0.09%810.73%21810.66%1355.47%
Mar 31, 2026400-2.91%23,705,2220.58%1050.96%194-10.19%1265.88%
Dec 31, 2025121-68.24%2,435,684-89.59%100.10%55-72.36%40-61.90%
Sep 30, 2025135-57.68%3,008,956-86.78%130.13%69-51.75%40-63.64%
Jun 30, 2025325-4.69%23,563,8530.96%1060.95%144-20.00%11118.09%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard US Total Market Shares ETF578.31K2.62%388.00
Vanguard Total Stock Mkt Idx Inv585.11K2.54%809.00
Vanguard Morn Total Stk Mkt Idx Investor585.11K2.53%809.00
Vanguard Health Care Inv521.93K2.26%77.79K
Janus Henderson Forty S429.42K1.86%-
Vanguard Small Cap Index423.04K1.83%801.00
iShares Russell 2000 ETF409.15K1.77%3.80K
Janus Concentrated Growth CF338.60K1.47%-90.81K
SPDR® S&P Biotech ETF299.46K1.34%670.00
Vanguard Small Cap Growth Index Inv244.33K1.06%6.68K

Recent Insider Transactions

DateNameRoleActivityValue
Jul 20, 2026Sibold William John President and CEOSell$150.07K
Jul 20, 2026Sibold William John President and CEOSell$296.87K
Jul 20, 2026Sibold William John President and CEOSell$59.82K
Jul 20, 2026Sibold William John President and CEOSell$75.98K
Jul 20, 2026Sibold William John President and CEOSell$147.16K

Insider Transactions Trends

DateBuySell
2026 Q3-10
2026 Q2-14
2026 Q1-83
2025 Q4-70
2025 Q35478

MDGL Ownership FAQ

Who Owns Madrigal Pharmaceuticals?

Madrigal Pharmaceuticals shareholders are primarily institutional investors at 81.81%, followed by 5.87% insiders and 12.32% retail investors. The average institutional ownership in Madrigal Pharmaceuticals's industry, Biotech Stocks , is 49.09%, which Madrigal Pharmaceuticals exceeds.

Who owns the most shares of Madrigal Pharmaceuticals?

Madrigal Pharmaceuticals’s largest shareholders are Janus henderson group (2.02M shares, 9.00%), Vanguard group (1.81M shares, 8.05%), and Baker bros. advisors lp (2.14M shares, 7.38%). Together, they hold 24.43% of Madrigal Pharmaceuticals’s total shares outstanding.

Does Blackrock own Madrigal Pharmaceuticals?

Yes, BlackRock owns 7.14% of Madrigal Pharmaceuticals, totaling 1.43M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 399.86M$. In the last quarter, BlackRock increased its holdings by 216.86K shares, a 17.92% change.

Who is Madrigal Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Paulson is Madrigal Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 27.94% of its assets in 1.34M Madrigal Pharmaceuticals shares, valued at 719.52M$.

Who is the top mutual fund holder of Madrigal Pharmaceuticals shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Madrigal Pharmaceuticals shares, with 2.62% of its total shares outstanding invested in 578.31K Madrigal Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools